NEW YORK & LYON, France--(BUSINESS WIRE)--Aug 14, 2026--
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
NEW YORK & LYON, France--(BUSINESS WIRE)--Aug 14, 2026--